Authors’ Reply to Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”

被引:0
|
作者
Edward E. Neuberger
Josh J. Carlson
David L. Veenstra
机构
[1] Genentech,The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, Department of Pharmacy
[2] Inc.,undefined
[3] University of Washington,undefined
来源
PharmacoEconomics | 2021年 / 39卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:477 / 478
页数:1
相关论文
共 50 条
  • [31] Cost-effectiveness of cognitive behaviour therapy versus talking and usual care for depressed older people in primary care
    Holman, Amanda J.
    Serfaty, Marc A.
    Leurent, Baptiste E.
    King, Michael B.
    BMC HEALTH SERVICES RESEARCH, 2011, 11
  • [32] Cost-effectiveness of cognitive behaviour therapy versus talking and usual care for depressed older people in primary care
    Amanda J Holman
    Marc A Serfaty
    Baptiste E Leurent
    Michael B King
    BMC Health Services Research, 11
  • [33] Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
    Oskar Eklund
    Faraz Afzal
    Fredrik Borgström
    Cost Effectiveness and Resource Allocation, 13
  • [34] Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
    Eklund, Oskar
    Afzal, Faraz
    Borgstrom, Fredrik
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
  • [35] Cost-Effectiveness Analysis of Laser Interstitial Thermal Therapy Versus Treatment as Usual for Mesial Temporal Lobe Epilepsy
    Reyes, Gabriel
    Gandhi, Ajay
    Kabotyanski, Katherine
    Hirani, Samad
    Liu, Tommy Bao-Lone
    Naqvi, Zain
    Hasen, Mohammed
    Provenza, Nicole
    Sheth, Sameer A.
    NEUROSURGERY, 2025, 71 : 144 - 144
  • [36] Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain
    Marina De Salas-Cansado
    Enrique Álvarez
    José M. Olivares
    Jose L. Carrasco
    M. Belén Ferro
    Javier Rejas
    Social Psychiatry and Psychiatric Epidemiology, 2013, 48 : 985 - 996
  • [37] Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain
    De Salas-Cansado, Marina
    Alvarez, Enrique
    Olivares, Jose M.
    Carrasco, Jose L.
    Belen Ferro, M.
    Rejas, Javier
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2013, 48 (06) : 985 - 996
  • [38] Cost-effectiveness Analysis of Evidence-Based, Stepped and Coordinated Care Versus Treatment as Usual for Individuals with Mental Disorders
    Konnopka, Alexander
    Koenig, Hannah
    Gallinat, Juergen
    Lambert, Martin
    Karow, Anne
    Peth, Judith
    Schulz, Holger
    Koenig, Hans-Helmut
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2023, 26 : S17 - S17
  • [39] Cost-effectiveness of cognitive-behavioral therapy versus treatment as usual for anxiety disorders in children with autism spectrum disorder
    van Steensel, F. J. A.
    Dirksen, C. D.
    Bogels, S. M.
    RESEARCH IN AUTISM SPECTRUM DISORDERS, 2014, 8 (02) : 127 - 137
  • [40] A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales
    Burke, Colin
    Crossan, Catriona
    Tyas, Emma
    Hemstock, Matthew
    Lee, Dawn
    Bowditch, Sally
    PHARMACOECONOMICS-OPEN, 2024, 8 (04) : 611 - 626